CervoMed Inc. Files 8-K: Other Events & Exhibits
Ticker: CRVO · Form: 8-K · Filed: Oct 1, 2024 · CIK: 1053691
| Field | Detail |
|---|---|
| Company | Cervomed Inc. (CRVO) |
| Form Type | 8-K |
| Filed Date | Oct 1, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-events, filing
TL;DR
CervoMed filed an 8-K for other events and exhibits on 9/26.
AI Summary
CervoMed Inc. filed an 8-K on October 1, 2024, reporting on events that occurred on September 26, 2024. The filing is categorized under 'Other Events' and 'Financial Statements and Exhibits'. The company, formerly known as Diffusion Pharmaceuticals Inc., RestorGenex Corp, and Stratus Media Group, Inc., is incorporated in Delaware and headquartered in Boston, MA.
Why It Matters
This 8-K filing indicates that CervoMed Inc. is providing updates on significant corporate events and financial information to the SEC, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- CervoMed Inc. (company) — Registrant
- Diffusion Pharmaceuticals Inc. (company) — Former company name
- RestorGenex Corp (company) — Former company name
- Stratus Media Group, Inc (company) — Former company name
- September 26, 2024 (date) — Date of earliest event reported
- October 1, 2024 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing for CervoMed Inc.?
The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' that occurred on September 26, 2024.
When was this 8-K report filed with the SEC?
This 8-K report was filed with the SEC on October 1, 2024.
What are some of the former names of CervoMed Inc. mentioned in the filing?
The filing mentions that CervoMed Inc. was formerly known as Diffusion Pharmaceuticals Inc., RestorGenex Corp, and Stratus Media Group, Inc.
In which state is CervoMed Inc. incorporated?
CervoMed Inc. is incorporated in Delaware.
What is the business address of CervoMed Inc.?
The business address of CervoMed Inc. is 20 Park Plaza, Suite 424, Boston, Massachusetts 02116.
Filing Stats: 452 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-10-01 08:00:58
Key Financial Figures
- $0.001 — on which registered Common Stock , $0.001 par value CRVO NASDAQ Capital Market
Filing Documents
- crvo20240930_8k.htm (8-K) — 29KB
- ex_728559.htm (EX-99.1) — 12KB
- logosm.jpg (GRAPHIC) — 10KB
- 0001437749-24-030299.txt ( ) — 188KB
- crvo-20240926.xsd (EX-101.SCH) — 3KB
- crvo-20240926_def.xml (EX-101.DEF) — 11KB
- crvo-20240926_lab.xml (EX-101.LAB) — 15KB
- crvo-20240926_pre.xml (EX-101.PRE) — 11KB
- crvo20240930_8k_htm.xml (XML) — 3KB
01
Item 8.01 Other Events On September 26, 2024, CervoMed Inc. (the "Company") issued a press release announcing that it will deliver two oral presentations that inform on the potential of neflamapimod as a treatment for patients with dementia with Lewy bodies (DLB) at the Clinical Trials on Alzheimer's Disease Conference (CTAD) taking place October 29 – November 1, 2024, in Madrid, Spain. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release, issued September 26, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 1, 2024 CervoMed Inc. By: /s/ William Elder Name: William Elder Title: Chief Financial Officer & General Counsel